an open pilot clinical study on Iraippu noi [bronchial asthma]with the evaluation of trial drug thennangal thiravagam

An open pilot clinical study on Swasa kasam [Bronchial Asthma]with the evaluation of trial drug Thennangal Thiravagam

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/08/004916

Enrollment

Registered

2014-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with symptoms of bronchial asthma

Interventions

Intervention1: NIL: dose-10 drops with 10ml hot water twice a day,duration 30 days,per oral Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Cough,Dyspnoea,Chest tightness,Wheeze, Willing to participate in the trial and sign in the consent form.

Exclusion criteria

Exclusion criteria: History of congestive cardiac failure. History of Bronchiectasis. History of Bronchogenic carcinoma. History of Chronic bronchitis. Vulnerable populations like pregnant and lactating women, HIV positive individuals and TB individuals

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by comparing the peak expiratory flow rate before and after treatmentTimepoint: 30 DAYS	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameterss before and after treatmentTimepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactDRKKANAKAVALLI MDS

Government siddha medical college

parniru@gmail.com9444284684

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026